NCT01579877

Brief Summary

The aims of this study are to investigate the effect of famous herbal formula extract on xerostomia, and to determine whether this formula affect various xerostomia-related questionnaires, salivary flow rate, residual saliva and salivary tests.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2012

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 18, 2012

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

May 14, 2013

Status Verified

May 1, 2013

Enrollment Period

1.4 years

First QC Date

April 13, 2012

Last Update Submit

May 12, 2013

Conditions

Keywords

XerostomiaYukmijihwang-tangYin-DeficiencyVisual analogue scaleDry mouth symptom questionnaire

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale (VAS) for xerostomia

    A 100 mm measurement instrument will be given to the patient and he will be instructed to indicate his severity of xerostomia in relation to the 2 extremes (0: no fatigue, 100: very severe fatigue).

    Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)

Secondary Outcomes (4)

  • Unstimulated Salivary Flow Rate (USFR) and Stimulated salivary flow rate (SSFR)

    Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)

  • Residual saliva

    Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)

  • Salivary IgA, Chromogranin A, Cortisol

    Visit 1(0week), Visit 3(8week)

  • Dry Mouth Symptom Questionnaire(DMSQ)

    Visit 1(0week), Visit 2(4week), Visit 3(8week), Visit 4(10week)

Study Arms (2)

Yukmijihwang-tang

EXPERIMENTAL

Yukmijihwang-tang: Real herbal extract granule

Dietary Supplement: Herbal extract granule

Yukmijihwang-tang_Placebo

PLACEBO COMPARATOR

Yukmijihwang-tang\_Placebo: Placebo herbal extract granule

Dietary Supplement: Placebo herbal extract granule

Interventions

Herbal extract granuleDIETARY_SUPPLEMENT

The herbal extract granule, Yukmijihwang-tang granule, consists of 6 herbs. Ingredients: Rehmanniae Radix, Deoscoreae Radix, Corni Fructus, Hoelen, Alismatis Radix, Paeoniae Radicis Cortex. Dosage and frequency: 1 pack (3g), 3 packs per day (2 hours after morning, afternoon and evening meal)

Also known as: Hexalong Granule
Yukmijihwang-tang

The Yukmijihwang-tang\_Placebo has the same form, color and flavor as experimental intervention (Yukmijihwang-tang). The dosage, frequency and duration is also the same as experimental intervention (Yukmijihwang-tang).

Also known as: Hexalong Granule Placebo
Yukmijihwang-tang_Placebo

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 60 - 80
  • The visual analog scale for xerostomia must represent more than 4 points during 2wks prior to enrollment
  • One who has less than 0.3 ml/min of unstimulated salivary flow rate
  • One who has complained of xerostomia for at least 3months
  • One who is able to read, write, hear, see something
  • One who agree on not taking other therapies during experimental period
  • One who agree on consent form

You may not qualify if:

  • One who is taking the treatment for autoimmune disease such as sjogren's disease, rheumatic disease, systemic lupus erythematosus etc
  • One who has the history of taking radiotherapy on head and neck or history of organ transplantation
  • One who has severe mental illness such as depression
  • One who takes oriental medicine or health functional food within 2 wks before enrollment
  • One who takes the remedies on the purpose of relieving xerostomia such as pilocarpine, cevimeline, gargle solution, frequent gum use, intra oral devices and toothpaste etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyung Hee University Oriental Medicine Hospital

Seoul, Seoul, 130-872, South Korea

RECRUITING

Related Publications (1)

  • Han G, Park JW, Ko SJ, Son J, Seon J, Kim J, Kim S, Yeo I, Ryu B, Kim J. Yukmijihwang-tang for the treatment of xerostomia in the elderly: study protocol for a randomized, double-blind, placebo-controlled, two-center trial. Trials. 2013 Sep 3;14:281. doi: 10.1186/1745-6215-14-281.

MeSH Terms

Conditions

XerostomiaYin Deficiency

Condition Hierarchy (Ancestors)

Salivary Gland DiseasesMouth DiseasesStomatognathic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jinsung Kim, doctorate

    Kyung Hee University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jinsung Kim, doctorate

CONTACT

Jae-Woo Park, doctorate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full professor

Study Record Dates

First Submitted

April 13, 2012

First Posted

April 18, 2012

Study Start

April 1, 2012

Primary Completion

September 1, 2013

Study Completion

November 1, 2013

Last Updated

May 14, 2013

Record last verified: 2013-05

Locations